Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jan
3
2024
 Unpacking Averages: The Seasonality of FDA 510(k) Decision-Making and the Impact of Michigan Playing for a National Championship Epstein Becker & Green, P.C.
Jan
3
2024
 FDA Supplements Response to D-Tagatose Petition Keller and Heckman LLP
Jan
3
2024
 FDA Issues Guidance on Reformulating Drug Products that Contain Carbomers Manufactured with Benzene Keller and Heckman LLP
Jan
3
2024
 APHIS Reopens Comment Period on Proposed Additional Exemptions for Plants Modified or Produced Through Genetic Engineering Bergeson & Campbell, P.C.
Jan
2
2024
 New U.S. Action Against Wine Bottle Imports Squire Patton Boggs (US) LLP
Jan
2
2024
 US State Law Roundup – 2023 Year-end Update Squire Patton Boggs (US) LLP
Jan
2
2024
 The Intertwining Nature of Motivation to Combine and Reasonable Expectation of Success Sheppard, Mullin, Richter & Hampton LLP
Jan
2
2024
 Looking Back and Moving Forward: MoCRA Regulatory Developments Ring in the New Year Mintz
Jan
2
2024
 Prop 12 Takes Full Effect in California Keller and Heckman LLP
Dec
29
2023
 OSTP Publishes Report on Vision, Needs, and Proposed Actions for Data for the Bioeconomy Initiative Bergeson & Campbell, P.C.
Dec
29
2023
 EPA Registers Novel Pesticide Technology for Potato Crops Bergeson & Campbell, P.C.
Dec
28
2023
 Two-Dimensional Barcodes: How 2D Could Change Retail Foley & Lardner LLP
Dec
27
2023
 NNI Publishes Economic Impact Analysis of 20 Years of Nanotechnology Investments Bergeson & Campbell, P.C.
Dec
27
2023
 Postal ServiceTM Proposes New Mailing Standards for Hazardous Materials Outer Packaging and Nonregulated Toxic Materials Bergeson & Campbell, P.C.
Dec
26
2023
 CMS Issues Revised Guidance Implementing Medicare Inflation Rebates Under the Inflation Reduction Act ArentFox Schiff LLP
Dec
23
2023
 China’s National Intellectual Property Administration to Allow Third-Party Challenges to Pharmaceutical Patent Term Extensions Schwegman, Lundberg & Woessner, P.A.
Dec
22
2023
 Private Investors and Digital Health Attracting OIG Attention: General Compliance Program Guidance to Watch McDermott Will & Emery
Dec
22
2023
 Medicare Provider and Supplier Enrollment Requirements: Program Integrity Changes for 2024 McDermott Will & Emery
Dec
21
2023
 China’s State Council Releases Amended Implementing Regulations of the Patent Law Schwegman, Lundberg & Woessner, P.A.
Dec
21
2023
 Pharmaceutical Companies Have Rights if the Federal Government Seized their Patents Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2023
 Inherent Limitations in Prior Patents can Lead to Obviousness-Type Double-Patenting Mintz
Dec
21
2023
 FDA Announces Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products ArentFox Schiff LLP
Dec
21
2023
 FSA Assesses Oyster Import Risks Keller and Heckman LLP
Dec
21
2023
 APHIS Extends Comment Period on Proposed Exemptions for Genetically Modified Plants Keller and Heckman LLP
Dec
21
2023
 Australia and New Zealand Consult on the First Cell-Cultured Meat Application Keller and Heckman LLP
Dec
20
2023
 2023: Another Year Chock Full of Challenges for FDA Mintz
Dec
20
2023
 Boosting Biotech: New York City Revives Tax Credits for Emerging Companies Mintz
Dec
20
2023
 A Win for Skinny Labels: Insights for Enforcing Use Patents Squire Patton Boggs (US) LLP
Displaying 1065 - 1092 of 11742
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins